Improving drug development with a vast map of the immune system
Immunai, founded by two researchers from MIT, is helping pharmaceutical companies identify the patients that stand to benefit most from new treatments.
Stay updated with breaking news from Luis Voloch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immunai, founded by two researchers from MIT, is helping pharmaceutical companies identify the patients that stand to benefit most from new treatments.
SuperUROP, an undergraduate research program, is celebrating its 10th year of existence at MIT. Four alumni of the program, each with different career paths, reflect on the ways their participation in SuperUROP helped them develop as scientists, researchers, entrepreneurs, and scholars.
SQUID is an innovative computational approach that would make single-cell RNA sequencing analyses more accessible, enabling doctors to personalize treatment decisions in efforts to improve the outcomes for their patients.
SQUID is an innovative computational approach that would make single-cell RNA sequencing analyses more accessible, enabling doctors to personalize treatment decisions in efforts to improve the outcomes for their patients.
Replit aims to empower the next billion software creators. In this week's episode of NVIDIA's AI Podcast, host Noah Kraviz dives into a conversation with Replit CEO Amjad Masad.... -Today at 01:22 pm- MarketScreener